© 2001 by Oxford University Press
Journal of the National Cancer Institute, Vol. 93, No. 21, 1638-1643,
November 7, 2001
© 2001 Oxford University Press
REPORT |
Expression of CC Chemokine Receptor-7 and Regional Lymph Node Metastasis of B16 Murine Melanoma
Affiliation of authors: Dermatology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Correspondence to: Sam T. Hwang, M.D., Ph.D., National Institutes of Health, Bldg. 10, Rm. 12N246, 10 Center Dr., MSC 1908, Bethesda, MD 20892–1908 (e-mail: hwangs{at}mail.nih.gov).
Background: CC chemokine receptor-7 (CCR7), which plays a critical role in the migration of activated dendritic cells to regional lymph nodes via afferent lymphatic vessels, is also expressed by human breast and melanoma cell lines. Because neoplastic cells also enter lymphatic vessels before metastasis to the lymph nodes, we investigated whether CCR7 expression enhances metastasis of B16 murine melanoma cells to regional lymph nodes. Methods: B16 cells were transduced with a retroviral vector containing CCR7 complementary DNA (CCR7-B16 cells) or with vector alone (pLNCX2-B16 control cells). The functional assay for CCR7 protein was Ca2+ flux stimulated by the chemokine CCL21, a CCR7-specific ligand produced by lymphatic endothelial cells. B16 tumor cells were injected into the footpad of mice. Tumor cell metastasis to draining lymph nodes was assessed by measuring messenger RNA (mRNA) for tyrosinase-related protein-1 (TRP), a melanocyte-specific enzyme, with real-time, quantitative reverse transcription–coupled polymerase chain reaction. All statistical tests were two-sided. Results: One week after injection into the footpad, 701-fold (95% confidence interval [CI] = 64- to 1336-fold) more TRP mRNA was detected in draining lymph nodes from CCR7-B16 cell-injected mice than in those from control cell-injected mice. Three weeks after footpad injection, 58% (11 of 19) of the draining lymph nodes from CCR7-B16 cell-injected mice and 5% (one of 19) of those from control mice showed gross metastases (P<.001). CCR7-B16 cells isolated from lymph node metastases retained functional CCR7 expression. Lymph node metastasis of CCR7-B16 cells was blocked by neutralizing anti-CCL21 antibodies (metastasis in none of five lymph nodes) but not by control immunoglobulin G (three of five). Enhanced metastasis of CCR7-B16 cells was specific for a lymphatic route because both CCR7-B16 and control cells co-injected intravenously metastasized to the lung at the same frequency. Conclusion: Expression of a single chemokine receptor gene, CCR7, increased B16 cell metastasis to draining lymph nodes, suggesting that cancer cells may co-opt normal mechanisms of lymph node homing during metastasis.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Lee, S. L. Auh, Y. Wang, B. Burnette, Y. Wang, Y. Meng, M. Beckett, R. Sharma, R. Chin, T. Tu, et al. Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment Blood, July 16, 2009; 114(3): 589 - 595. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-Y. Feng, Z.-L. Ou, F.-Y. Wu, Z.-Z. Shen, and Z.-M. Shao Involvement of a Novel Chemokine Decoy Receptor CCX-CKR in Breast Cancer Growth, Metastasis and Patient Survival Clin. Cancer Res., May 1, 2009; 15(9): 2962 - 2970. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-R. Pan, H.-C. Chang, Y.-C. Wu, C.-C. Huang, and W.-C. Hung Tubocapsanolide A Inhibits Transforming Growth Factor-{beta}-activating Kinase 1 to Suppress NF-{kappa}B-induced CCR7 J. Biol. Chem., January 30, 2009; 284(5): 2746 - 2754. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Issa, T. X. Le, A. N. Shoushtari, J. D. Shields, and M. A. Swartz Vascular Endothelial Growth Factor-C and C-C Chemokine Receptor 7 in Tumor Cell-Lymphatic Cross-talk Promote Invasive Phenotype Cancer Res., January 1, 2009; 69(1): 349 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Fang, V. C. Lee, E. Cha, H. Zhang, and S. T. Hwang CCR7 regulates B16 murine melanoma cell tumorigenesis in skin J. Leukoc. Biol., October 1, 2008; 84(4): 965 - 972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wang, R. R. Seethala, Q. Zhang, W. Gooding, C. van Waes, H. Hasegawa, and R. L. Ferris Autocrine and Paracrine Chemokine Receptor 7 Activation in Head and Neck Cancer: Implications for Therapy J Natl Cancer Inst, April 2, 2008; 100(7): 502 - 512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Li, H. Alizadeh, and J. Y. Niederkorn Differential Expression of Chemokine Receptors on Uveal Melanoma Cells and Their Metastases Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 636 - 643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Wallace, R. L. Prueitt, M. Yi, T. M. Howe, J. W. Gillespie, H. G. Yfantis, R. M. Stephens, N. E. Caporaso, C. A. Loffredo, and S. Ambs Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men Cancer Res., February 1, 2008; 68(3): 927 - 936. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Kodama, Hasengaowa, T Kusumoto, N Seki, T Matsuo, Y Ojima, K Nakamura, A Hongo, and Y Hiramatsu Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer Ann. Onc., January 1, 2007; 18(1): 70 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Azzali Tumor Cell Transendothelial Passage in the Absorbing Lymphatic Vessel of Transgenic Adenocarcinoma Mouse Prostate Am. J. Pathol., January 1, 2007; 170(1): 334 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sugaya, L. Fang, A. R. Cardones, T. Kakinuma, S. H. Jaber, A. Blauvelt, and S. T. Hwang Oncostatin M Enhances CCL21 Expression by Microvascular Endothelial Cells and Increases the Efficiency of Dendritic Cell Trafficking to Lymph Nodes J. Immunol., December 1, 2006; 177(11): 7665 - 7672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Scheibenbogen, P. Ghadjar, and U. Keilholz In Reply J. Clin. Oncol., November 10, 2006; 24(32): 5174 - 5174. [Full Text] [PDF]
|
|
|
|
|
|
N. E. Tobler and M. Detmar Tumor and lymph node lymphangiogenesis--impact on cancer metastasis J. Leukoc. Biol., October 1, 2006; 80(4): 691 - 696. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Shayan, M. G. Achen, and S. A. Stacker Lymphatic vessels in cancer metastasis: bridging the gaps Carcinogenesis, September 1, 2006; 27(9): 1729 - 1738. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Andre, N. Cabioglu, H. Assi, J. C. Sabourin, S. Delaloge, A. Sahin, K. Broglio, J. P. Spano, C. Combadiere, C. Bucana, et al. Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer Ann. Onc., June 1, 2006; 17(6): 945 - 951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kakinuma and S. T. Hwang Chemokines, chemokine receptors, and cancer metastasis J. Leukoc. Biol., April 1, 2006; 79(4): 639 - 651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kanao, T. Enomoto, T. Kimura, M. Fujita, R. Nakashima, Y. Ueda, Y. Ueno, T. Miyatake, T. Yoshizaki, G. S. Buzard, et al. Overexpression of LAMP3/TSC403/DC-LAMP Promotes Metastasis in Uterine Cervical Cancer Cancer Res., October 1, 2005; 65(19): 8640 - 8645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Cabioglu, M. S. Yazici, B. Arun, K. R. Broglio, G. N. Hortobagyi, J. E. Price, and A. Sahin CCR7 and CXCR4 as Novel Biomarkers Predicting Axillary Lymph Node Metastasis in T1 Breast Cancer Clin. Cancer Res., August 15, 2005; 11(16): 5686 - 5693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hu, X. Deng, X. Bian, G. Li, Y. Tong, Y. Li, Q. Wang, R. Xin, X. He, G. Zhou, et al. The Expression of Functional Chemokine Receptor CXCR4 Is Associated with the Metastatic Potential of Human Nasopharyngeal Carcinoma Clin. Cancer Res., July 1, 2005; 11(13): 4658 - 4665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Di Tommaso, D. Rahal, G. Bresciani, and M. Roncalli Cutaneous Melanoma Metastatic to Uterine Adenomyoma: Report of a Case International Journal of Surgical Pathology, April 1, 2005; 13(2): 223 - 225. [Abstract] [PDF]
|
|
|
|
|
|
C. C. Schimanski, S. Schwald, N. Simiantonaki, C. Jayasinghe, U. Gonner, V. Wilsberg, T. Junginger, M. R. Berger, P. R. Galle, and M. Moehler Effect of Chemokine Receptors CXCR4 and CCR7 on the Metastatic Behavior of Human Colorectal Cancer Clin. Cancer Res., March 1, 2005; 11(5): 1743 - 1750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kawada, M. Sonoshita, H. Sakashita, A. Takabayashi, Y. Yamaoka, T. Manabe, K. Inaba, N. Minato, M. Oshima, and M. M. Taketo Pivotal Role of CXCR3 in Melanoma Cell Metastasis to Lymph Nodes Cancer Res., June 1, 2004; 64(11): 4010 - 4017. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Bartolome, B. G. Galvez, N. Longo, F. Baleux, G. N. P. van Muijen, P. Sanchez-Mateos, A. G. Arroyo, and J. Teixido Stromal Cell-Derived Factor-1{alpha} Promotes Melanoma Cell Invasion across Basement Membranes Involving Stimulation of Membrane-Type 1 Matrix Metalloproteinase and Rho GTPase Activities Cancer Res., April 1, 2004; 64(7): 2534 - 2543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wang, L. Xi, J. L. Hunt, W. Gooding, T. L. Whiteside, Z. Chen, T. E. Godfrey, and R. L. Ferris Expression Pattern of Chemokine Receptor 6 (CCR6) and CCR7 in Squamous Cell Carcinoma of the Head and Neck Identifies a Novel Metastatic Phenotype Cancer Res., March 1, 2004; 64(5): 1861 - 1866. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Murakami, A. R. Cardones, S. E. Finkelstein, N. P. Restifo, B. A. Klaunberg, F. O. Nestle, S. S. Castillo, P. A. Dennis, and S. T. Hwang Immune Evasion by Murine Melanoma Mediated through CC Chemokine Receptor-10 J. Exp. Med., November 3, 2003; 198(9): 1337 - 1347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Pepper and M. Skobe Lymphatic endothelium: morphological, molecular and functional properties J. Cell Biol., October 27, 2003; 163(2): 209 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Cardones, T. Murakami, and S. T. Hwang CXCR4 Enhances Adhesion of B16 Tumor Cells to Endothelial Cells in Vitro and in Vivo via {beta}1 Integrin Cancer Res., October 15, 2003; 63(20): 6751 - 6757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ding, Y. Shimada, M. Maeda, A. Kawabe, J. Kaganoi, I. Komoto, Y. Hashimoto, M. Miyake, H. Hashida, and M. Imamura Association of CC Chemokine Receptor 7 with Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma Clin. Cancer Res., August 1, 2003; 9(9): 3406 - 3412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hirakawa, Y.-K. Hong, N. Harvey, V. Schacht, K. Matsuda, T. Libermann, and M. Detmar Identification of Vascular Lineage-Specific Genes by Transcriptional Profiling of Isolated Blood Vascular and Lymphatic Endothelial Cells Am. J. Pathol., February 1, 2003; 162(2): 575 - 586. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Murakami, W. Maki, A. R. Cardones, H. Fang, A. Tun Kyi, F. O. Nestle, and S. T. Hwang Expression of CXC Chemokine Receptor-4 Enhances the Pulmonary Metastatic Potential of Murine B16 Melanoma Cells Cancer Res., December 1, 2002; 62(24): 7328 - 7334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Detmar and S. Hirakawa The Formation of Lymphatic Vessels and Its Importance in the Setting of Malignancy J. Exp. Med., September 16, 2002; 196(6): 713 - 718. [Full Text] [PDF]
|
|
|
|
|
|
K. Mashino, N. Sadanaga, H. Yamaguchi, F. Tanaka, M. Ohta, K. Shibuta, H. Inoue, and M. Mori Expression of Chemokine Receptor CCR7 Is Associated with Lymph Node Metastasis of Gastric Carcinoma Cancer Res., May 1, 2002; 62(10): 2937 - 2941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Oliver and M. Detmar The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature Genes & Dev., April 1, 2002; 16(7): 773 - 783. [Full Text] [PDF]
|
|
|
|
|
|
R. Forster, L. Ohl, and G. Henning Lessons Learned From Lymphocytes: CC Chemokine Receptor-7 Involved in Lymphogenic Metastasis of Melanoma J Natl Cancer Inst, November 7, 2001; 93(21): 1588 - 1589. [Full Text] [PDF]
|
|